Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Dec 23, 2023 2:26pm
Merry Christmas All
What a great pivot it's been. New formulation, safer product and more control. Let's see where they take that in 2024 as we go to P2 for Acute and as they use DILIsym to plan out a
...more
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 20, 2023 12:49pm
Also
most experts think a pullback in the (record high)market early in the newyear. a buying opportunity to get back in cheaper next year.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 24, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 20, 2023 12:44pm
Antibe selling off
today, no surprise the stock got ahead of itself. still a long way away untill start of P2 most likely not until march, and results not untill september 2024
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 14, 2023 8:01am
A Conversation With Antibe Therapeutics
15 Prince Arthur Ave. Toronto, ON, Canada, M5R 1B2 TSX:ATE OTCQX:ATBPF antibethera.com
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Dec 12, 2023 7:02am
New Press Release - Antibe Therapeutics Announces Amendment to Warrant Terms
Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF) (the "Company"), a clinical stage company leveraging its hydrogen sulfide platform to develop next-generation safer therapies that target inflammation, announces that it is extending the expiry date (the “Warrant Extension”), and amending the...
read article.
(12)
•••
Jefnan1
X
View Profile
View Bullboard History
Comment by
Jefnan1
on Dec 11, 2023 12:14pm
RE:RE:RE:RE:RE:Picked up another
I'm aware of that because my price is $1.60 but I believed and still believe I will do better. I have chosen to hold on since they have proof of concept as to the lack of bleeding
...more
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Dec 11, 2023 10:40am
RE:RE:RE:RE:Picked up another
on feb/17/2021 ATE toped out@ $7.52 (and that was before P3) so i think mcwhirter was a little light on his price target of $8 to $10, why did you not take profit? looks like you will get
...more
(12)
•••
Jefnan1
X
View Profile
View Bullboard History
Comment by
Jefnan1
on Dec 11, 2023 9:34am
RE:RE:RE:Picked up another
My point is that any private S/H like myself already have their big positions and have held them for years
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Dec 11, 2023 12:50am
RE:RE:Picked up another
@70 cents no big players are in yet, but soon i think they will be taking a position ahead of P2 results. if all goes good names like bayer and tylenol have been thrown around as potential take out
...more
(12)
•••
Jefnan1
X
View Profile
View Bullboard History
Comment by
Jefnan1
on Dec 08, 2023 4:19pm
RE:Picked up another
I have owned what you would call a big position for over 10 years. My question for you is why you think there are any so called big fish waiting to buy shares. The only way any small S/H get out
...more
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 08, 2023 2:54pm
Picked up another
5k today, i think iam good for now already own too much lol. just a waiting game now before the big fish start to bite. will it be early january or maybe some will want to be in before the newyear
...more
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 05, 2023 10:58pm
P2 jan/1 to march/31
In light of the strong safety and PK data from otenaproxesul’s recent clinical PK/PD study, Antibe is upgrading the design of the upcoming fully-funded Phase II trial. While trial initiation remains
...more
(1)
•••
Cdnguy81
X
View Profile
View Bullboard History
Comment by
Cdnguy81
on Dec 05, 2023 6:34pm
RE:Our christmas gift
Actually, phase 2 is not starting in January. It is starting in March, per I.R.
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Dec 04, 2023 10:03am
Our christmas gift
from antibe will be a news release in early january saying "phase 2 has begun" and then it is off to the races, we will see institunial buying, the stock price will make a violent move up
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Dec 03, 2023 6:05pm
Twas the night before ... and all through the house ...
This is how we look at it ... If you look at the Singapore Court System, it is reasonable to believe that ATE already has the results and they are formulating their response to shareholders. Else ..
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >